Doctors, economists, lawmakers, and civil society groups fighting the WTO waiver are funded by the pharmaceutical lobby.JUST BEFORE GOING live on Al Jazeera last week, Achal Prabhala, an activist for equitable access to medicine, performed a quick internet search on his sparring partner in a debate on the proposal to share vaccine technology with low-income countries.It didn’t take long before Prabhala found that his opponent, an academic who favors pharmaceutical monopoly rights, leads an institute at Duke University funded by Pfizer and AstraZeneca. He pointed this fact out to the producers on air.The apparent conflict of interest is hardly a rare occurrence.The InterceptLee Fang - DRUG INDUSTRY MONEY QUIETLY BACKS MEDIA VOICES AGAINST SHARING VACCINE PATENTS
Topics:
Mike Norman considers the following as important:
This could be interesting, too:
Peter Radford writes Lost opportunities?
Joel Eissenberg writes Oh, Elon!
Angry Bear writes Role Of Medicaid Accountable Care Orgs In Maternal Health
NewDealdemocrat writes April consumer prices: still an interplay of gas and house prices, with a side helping of motor vehicle insurance
Doctors, economists, lawmakers, and civil society groups fighting the WTO waiver are funded by the pharmaceutical lobby.
JUST BEFORE GOING live on Al Jazeera last week, Achal Prabhala, an activist for equitable access to medicine, performed a quick internet search on his sparring partner in a debate on the proposal to share vaccine technology with low-income countries.
It didn’t take long before Prabhala found that his opponent, an academic who favors pharmaceutical monopoly rights, leads an institute at Duke University funded by Pfizer and AstraZeneca. He pointed this fact out to the producers on air.
The apparent conflict of interest is hardly a rare occurrence.
The Intercept
Lee Fang - DRUG INDUSTRY MONEY QUIETLY BACKS MEDIA VOICES AGAINST SHARING VACCINE PATENTS